Pictet Asset Management
CRBU icon

Pictet Asset Management’s Caribou Biosciences CRBU Stock Holding History

Pictet Asset Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-940,911
Closed -$5.39M – 1979
2023
Q4 		$5.39M Sell
940,911
-988,478
-51% -$4.89M 0.01% 774
2023
Q3 		$9.22M Buy
+1,929,389
New +$12M 0.01% 637

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management's CRBU Position: Q1 2024 in Review

Pictet Asset Management sold out of Caribou Biosciences (CRBU) in Q1 2024, closing a stake of 940,911 shares — an estimated $5.39M sold.

Pictet Asset Management first reported a position in CRBU in Q3 2023 and held it in 2 quarters. The position peaked at $9.22M in Q3 2023. 151 funds tracked by Wall St. Rank hold CRBU as of Q1 2024.

  • Pictet Asset Management reported no remaining Caribou Biosciences position as of Q1 2024 after selling out during the quarter.
  • Pictet Asset Management sold 940,911 Caribou Biosciences shares in Q1 2024, an estimated $5.39M.
  • Pictet Asset Management first reported a position in Caribou Biosciences in Q3 2023 and held it in 2 quarters.
  • Pictet Asset Management's Caribou Biosciences position peaked at $9.22M in Q3 2023.
  • 151 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2024.

Based on Pictet Asset Management's 13F filing for Q1 2024, filed 14 May 2024.